210 related articles for article (PubMed ID: 36732772)
1. Lung Inflammation in alpha-1-antitrypsin deficient individuals with normal lung function.
Kokturk N; Khodayari N; Lascano J; Riley EL; Brantly ML
Respir Res; 2023 Feb; 24(1):40. PubMed ID: 36732772
[TBL] [Abstract][Full Text] [Related]
2. Cigarette smoke exposed airway epithelial cell-derived EVs promote pro-inflammatory macrophage activation in alpha-1 antitrypsin deficiency.
Khodayari N; Oshins R; Mehrad B; Lascano JE; Qiang X; West JR; Holliday LS; Lee J; Wiesemann G; Eydgahi S; Brantly M
Respir Res; 2022 Sep; 23(1):232. PubMed ID: 36068572
[TBL] [Abstract][Full Text] [Related]
3. Small airways disease in patients with alpha-1 antitrypsin deficiency.
Toumpanakis D; Usmani OS
Respir Med; 2023 May; 211():107222. PubMed ID: 36965591
[TBL] [Abstract][Full Text] [Related]
4. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
Rahaghi FF; Miravitlles M
Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
[TBL] [Abstract][Full Text] [Related]
5. Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD.
Balbi B; Sangiorgi C; Gnemmi I; Ferrarotti I; Vallese D; Paracchini E; Delle Donne L; Corda L; Baderna P; Corsico A; Carone M; Brun P; Cappello F; Ricciardolo FL; Ruggeri P; Mumby S; Adcock IM; Caramori G; Di Stefano A
Int J Chron Obstruct Pulmon Dis; 2019; 14():1879-1893. PubMed ID: 31686800
[TBL] [Abstract][Full Text] [Related]
6. Role of human neutrophil peptides in lung inflammation associated with alpha1-antitrypsin deficiency.
Spencer LT; Paone G; Krein PM; Rouhani FN; Rivera-Nieves J; Brantly ML
Am J Physiol Lung Cell Mol Physiol; 2004 Mar; 286(3):L514-20. PubMed ID: 14594730
[TBL] [Abstract][Full Text] [Related]
7. Alpha 1 Antitrypsin-Deficient Macrophages Have Impaired Efferocytosis of Apoptotic Neutrophils.
Lee J; Lu Y; Oshins R; West J; Moneypenny CG; Han K; Brantly ML
Front Immunol; 2020; 11():574410. PubMed ID: 33329539
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease.
Stoller JK; Aboussouan LS; Kanner RE; Wilson LA; Diaz P; Wise R;
Ann Am Thorac Soc; 2015 Dec; 12(12):1796-804. PubMed ID: 26653189
[TBL] [Abstract][Full Text] [Related]
9. Immune activation in α1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigm.
Baraldo S; Turato G; Lunardi F; Bazzan E; Schiavon M; Ferrarotti I; Molena B; Cazzuffi R; Damin M; Balestro E; Luisetti M; Rea F; Calabrese F; Cosio MG; Saetta M
Am J Respir Crit Care Med; 2015 Feb; 191(4):402-9. PubMed ID: 25412116
[TBL] [Abstract][Full Text] [Related]
10. Alpha-1 Antitrypsin Augmentation Inhibits Proteolysis of Neutrophil Membrane Voltage-Gated Proton Channel-1 in Alpha-1 Deficient Individuals.
Hawkins P; Sya J; Hup NK; Murphy MP; McElvaney NG; Reeves EP
Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441020
[No Abstract] [Full Text] [Related]
11. The BLT1 Inhibitory Function of α-1 Antitrypsin Augmentation Therapy Disrupts Leukotriene B4 Neutrophil Signaling.
O'Dwyer CA; O'Brien ME; Wormald MR; White MM; Banville N; Hurley K; McCarthy C; McElvaney NG; Reeves EP
J Immunol; 2015 Oct; 195(8):3628-41. PubMed ID: 26371243
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory cytokine response to exercise in alpha-1-antitrypsin deficient COPD patients 'on' or 'off' augmentation therapy.
Olfert IM; Malek MH; Eagan TM; Wagner H; Wagner PD
BMC Pulm Med; 2014 Jun; 14():106. PubMed ID: 24975928
[TBL] [Abstract][Full Text] [Related]
13. Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review.
Edgar RG; Patel M; Bayliss S; Crossley D; Sapey E; Turner AM
Int J Chron Obstruct Pulmon Dis; 2017; 12():1295-1308. PubMed ID: 28496314
[TBL] [Abstract][Full Text] [Related]
14. Alpha-1-Antitrypsin Deficiency: Disease Management and Learning from Studies.
Greulich T
COPD; 2017 Mar; 14(sup1):S8-S11. PubMed ID: 28306355
[TBL] [Abstract][Full Text] [Related]
15. Decline in FEV
Hiller AM; Piitulainen E; Jehpsson L; Tanash H
Int J Chron Obstruct Pulmon Dis; 2019; 14():1075-1083. PubMed ID: 31213789
[No Abstract] [Full Text] [Related]
16. The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency.
McCarthy C; Reeves EP; McElvaney NG
Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S297-304. PubMed ID: 27564664
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology of Alpha-1 Antitrypsin Lung Disease.
Kalfopoulos M; Wetmore K; ElMallah MK
Methods Mol Biol; 2017; 1639():9-19. PubMed ID: 28752442
[TBL] [Abstract][Full Text] [Related]
18. Clarifying the Risk of Lung Disease in SZ Alpha-1 Antitrypsin Deficiency.
Franciosi AN; Hobbs BD; McElvaney OJ; Molloy K; Hersh C; Clarke L; Gunaratnam C; Silverman EK; Carroll TP; McElvaney NG
Am J Respir Crit Care Med; 2020 Jul; 202(1):73-82. PubMed ID: 32197047
[No Abstract] [Full Text] [Related]
19. Cardiovascular disease in Alpha 1 antitrypsin deficiency: an observational study assessing the role of neutrophil proteinase activity and the suitability of validated screening tools.
Sapey E; Crowley LE; Edgar RG; Griffiths D; Samanta S; Crisford H; Bolton CE; Hurst JR; Stockley RA
Orphanet J Rare Dis; 2024 Mar; 19(1):130. PubMed ID: 38515138
[TBL] [Abstract][Full Text] [Related]
20. Gene coexpression networks reveal novel molecular endotypes in alpha-1 antitrypsin deficiency.
Chu JH; Zang W; Vukmirovic M; Yan X; Adams T; DeIuliis G; Hu B; Mihaljinec A; Schupp JC; Becich MJ; Hochheiser H; Gibson KF; Chen ES; Morris A; Leader JK; Wisniewski SR; Zhang Y; Sciurba FC; Collman RG; Sandhaus R; Herzog EL; Patterson KC; Sauler M; Strange C; Kaminski N;
Thorax; 2021 Feb; 76(2):134-143. PubMed ID: 33303696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
